Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (13193)	9/29/2004 9:53:53 AM
From: rkrw	Read Replies (2) of 52153

AGIX is a tough call now. If cart II confirms the interim data agix could be a $100 stock before long. Not confirmed then the binary event pushes out to the arise (events) and becomes very high risk. agix also has strong partner prospects now, could well be an auction environment with the statin makers. arise bombs this will be a notable crash and burn for all :-) I saw agix present a few wks ago as I noted on another board. What's interesting is that as it turns out shorts did have good info that an interim look and statistical hit was taken. Now I know why ceo was sweating profusely. Ironically the priveleged info turned out to be detrimental to shorts. P.S. I keep pressing submit thinking it's a preview.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next